The prescription division is undoubtedly one of Normon’s major strengths.

It consists of both brand-name and generic medicinal products.

Currently, Normon commercializes 270 presentations and 75 drug substances, with a further 30 molecules currently in the licensing or development phase.

Normon is currently the third largest Spanish laboratory in terms of prescription market sales, and the largest in the generics market.

<< Previous

Next >>